from Muscular Dystrophy News by Ines Martins –
Researchers from the CNRS have discovered the molecular mechanisms responsible for the heart dysfunctions that mark myotonic dystrophy, and reported they appear to be linked to a defective processing of the cardiac sodium channel (SCN5A) RNA. Their study, published in Nature Communications, is titled “Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhytmia in myotonic dystrophy.”
Myotonic dystrophy (DM), the most common adult-onset muscular dystrophy, is a genetic condition characterized by a wasting of skeletal muscle and heart defects, such as arrhythmia. It currently has no approved treatments.
It is caused by mutations that lead to the expansion of specific nucleotide repeats in one of two genes, depending on the genetic form of DM. The RNAs derived from these mutated genes accumulate and interfere with RNA-binding proteins that in turn modify the processing, known as mRNA splicing, of other RNAs.
Misregulation of the splicing of the insulin receptor, muscle chloride channel, or dysthrophin mRNAs are known to be associated with insulin resistance, myotonia, and dystrophic processes, respectively. However, the molecular mechanisms responsible for the cardiac defects, the second most common cause of death in DM, were not known.
In this study, an international team that included researchers from France, Japan, Germany, Finland, the U.S. and Spain, used RNA sequencing to reveal novel splicing alterations in DM heart samples, including a modification in the splicing pattern of SCN5A RNA. The molecular mechanisms that lead to the alteration of SCN5A were also clarified, and linked to the RNA-binding proteins that are altered upon the expression of mutated RNAs.
Identification of novel splicing misregulations in DM1 heart samples

(a) Δ-PSI versus Z-score plot of exon cassettes misregulations predicted by MISO analysis. (b) Exons structure and coverage of RNA-seq reads across SCN5A exons 5–7 show increased inclusion of exon 6A and decreased inclusion of exon 6B in heart samples of three DM1 patients (bottom, blue) versus three control samples (top, red).
A collaboration with Denis Furling at the Institute de Myologie, Paris, enabled the reproduction of the newly found splicing alteration of SCN5A in mice. Importantly, mice with an alternatively spliced form of SCN5A had cardiac dysfunctions similar to those observed in DM patients, suggesting that alternative splicing of SCN5A may contribute to DM cardiac dysfunctions.
“The next step would be to see if, by restoring correct splicing of SCN5A, we can also successfully restore normal heart function,” Nicolas Charlet-Berguerand, research director at Inserm and the study’s lead author, said in a press release. The researchers expect that their findings will lead to new research into this rare disease.
Source – Muscular Dystrophy News
[box type=”shadow” align=”alignleft” ]Freyermuth F et al. (2016)
Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy.
Nat Commun 7:11067. [
article][/fusion_text][/fusion_builder_column_inner][/fusion_builder_row_inner][/fusion_builder_column]
from Muscular Dystrophy News by Ines Martins –
Researchers from the CNRS have discovered the molecular mechanisms responsible for the heart dysfunctions that mark myotonic dystrophy, and reported they appear to be linked to a defective processing of the cardiac sodium channel (SCN5A) RNA. Their study, published in Nature Communications, is titled “Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhytmia in myotonic dystrophy.”
Myotonic dystrophy (DM), the most common adult-onset muscular dystrophy, is a genetic condition characterized by a wasting of skeletal muscle and heart defects, such as arrhythmia. It currently has no approved treatments.
It is caused by mutations that lead to the expansion of specific nucleotide repeats in one of two genes, depending on the genetic form of DM. The RNAs derived from these mutated genes accumulate and interfere with RNA-binding proteins that in turn modify the processing, known as mRNA splicing, of other RNAs.
Misregulation of the splicing of the insulin receptor, muscle chloride channel, or dysthrophin mRNAs are known to be associated with insulin resistance, myotonia, and dystrophic processes, respectively. However, the molecular mechanisms responsible for the cardiac defects, the second most common cause of death in DM, were not known.
In this study, an international team that included researchers from France, Japan, Germany, Finland, the U.S. and Spain, used RNA sequencing to reveal novel splicing alterations in DM heart samples, including a modification in the splicing pattern of SCN5A RNA. The molecular mechanisms that lead to the alteration of SCN5A were also clarified, and linked to the RNA-binding proteins that are altered upon the expression of mutated RNAs.
Identification of novel splicing misregulations in DM1 heart samples
(a) Δ-PSI versus Z-score plot of exon cassettes misregulations predicted by MISO analysis. (b) Exons structure and coverage of RNA-seq reads across SCN5A exons 5–7 show increased inclusion of exon 6A and decreased inclusion of exon 6B in heart samples of three DM1 patients (bottom, blue) versus three control samples (top, red).
A collaboration with Denis Furling at the Institute de Myologie, Paris, enabled the reproduction of the newly found splicing alteration of SCN5A in mice. Importantly, mice with an alternatively spliced form of SCN5A had cardiac dysfunctions similar to those observed in DM patients, suggesting that alternative splicing of SCN5A may contribute to DM cardiac dysfunctions.
“The next step would be to see if, by restoring correct splicing of SCN5A, we can also successfully restore normal heart function,” Nicolas Charlet-Berguerand, research director at Inserm and the study’s lead author, said in a press release. The researchers expect that their findings will lead to new research into this rare disease.
Source – Muscular Dystrophy News
[box type=”shadow” align=”alignleft” ]Freyermuth F et al. (2016) Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy. Nat Commun 7:11067. [article][/fusion_text][/fusion_builder_column_inner][/fusion_builder_row_inner][/fusion_builder_column]Related Posts
Researchers create first whole-body single-cell atlas of an adult vertebrate
UAlbany Joins $10 Million Effort to Map RNA Modifications in the Human Body
Overlooked ‘off switch’ in lung tumors may explain why immunotherapy doesn’t work for everyone
Squids Edit RNA for Novel Protein Functions
New marker panel and web tool help define early human cell fates
Researchers Develop AI Tool to Map MicroRNA Binding Sites on Circular RNAs
“Raman Genome” for SARS-CoV-2: new Raman technology distinguishes viral variants by their molecular RNA architecture
Advanced paternal age has sex-specific effects on fetal brain gene expression
Exercise is good for us—but why?
Heart failure reshapes bone marrow to create inflammation-related immune memory
Overlooked DNA regions surrounding ‘microexons’ hold missing pieces of autism’s genetic puzzle
An anti-senescence gene may fight spinal disc deterioration
Scientists identify the neuroblastoma cells that signal poor outcomes
Urine test may improve bladder cancer diagnosis and guide treatment decisions
Tracing 700 million years of cell evolution
RNA-Seq reveals a new way the developing heart controls its growth
The Human RNome Project Consortium seeks to publish first-ever complete sequence of the body’s RNA
Unmasking “zombie cells” in aging tissue with an AI-powered barcode
RNA variant imaging for cancer diagnosis
Autism-risk mutations reveal two opposing patterns of brain gene activity
from Muscular Dystrophy News by Ines Martins –
Researchers from the CNRS have discovered the molecular mechanisms responsible for the heart dysfunctions that mark myotonic dystrophy, and reported they appear to be linked to a defective processing of the cardiac sodium channel (SCN5A) RNA. Their study, published in Nature Communications, is titled “Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhytmia in myotonic dystrophy.”
Myotonic dystrophy (DM), the most common adult-onset muscular dystrophy, is a genetic condition characterized by a wasting of skeletal muscle and heart defects, such as arrhythmia. It currently has no approved treatments.
It is caused by mutations that lead to the expansion of specific nucleotide repeats in one of two genes, depending on the genetic form of DM. The RNAs derived from these mutated genes accumulate and interfere with RNA-binding proteins that in turn modify the processing, known as mRNA splicing, of other RNAs.
Misregulation of the splicing of the insulin receptor, muscle chloride channel, or dysthrophin mRNAs are known to be associated with insulin resistance, myotonia, and dystrophic processes, respectively. However, the molecular mechanisms responsible for the cardiac defects, the second most common cause of death in DM, were not known.
In this study, an international team that included researchers from France, Japan, Germany, Finland, the U.S. and Spain, used RNA sequencing to reveal novel splicing alterations in DM heart samples, including a modification in the splicing pattern of SCN5A RNA. The molecular mechanisms that lead to the alteration of SCN5A were also clarified, and linked to the RNA-binding proteins that are altered upon the expression of mutated RNAs.
Identification of novel splicing misregulations in DM1 heart samples
(a) Δ-PSI versus Z-score plot of exon cassettes misregulations predicted by MISO analysis. (b) Exons structure and coverage of RNA-seq reads across SCN5A exons 5–7 show increased inclusion of exon 6A and decreased inclusion of exon 6B in heart samples of three DM1 patients (bottom, blue) versus three control samples (top, red).
A collaboration with Denis Furling at the Institute de Myologie, Paris, enabled the reproduction of the newly found splicing alteration of SCN5A in mice. Importantly, mice with an alternatively spliced form of SCN5A had cardiac dysfunctions similar to those observed in DM patients, suggesting that alternative splicing of SCN5A may contribute to DM cardiac dysfunctions.
“The next step would be to see if, by restoring correct splicing of SCN5A, we can also successfully restore normal heart function,” Nicolas Charlet-Berguerand, research director at Inserm and the study’s lead author, said in a press release. The researchers expect that their findings will lead to new research into this rare disease.
Source – Muscular Dystrophy News
[box type=”shadow” align=”alignleft” ]Freyermuth F et al. (2016) Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy. Nat Commun 7:11067. [article][/fusion_text][/fusion_builder_column_inner][/fusion_builder_row_inner][/fusion_builder_column]Related Posts
Researchers create first whole-body single-cell atlas of an adult vertebrate
UAlbany Joins $10 Million Effort to Map RNA Modifications in the Human Body
Overlooked ‘off switch’ in lung tumors may explain why immunotherapy doesn’t work for everyone
Squids Edit RNA for Novel Protein Functions
New marker panel and web tool help define early human cell fates
Researchers Develop AI Tool to Map MicroRNA Binding Sites on Circular RNAs
“Raman Genome” for SARS-CoV-2: new Raman technology distinguishes viral variants by their molecular RNA architecture
Advanced paternal age has sex-specific effects on fetal brain gene expression
Exercise is good for us—but why?
Heart failure reshapes bone marrow to create inflammation-related immune memory
Overlooked DNA regions surrounding ‘microexons’ hold missing pieces of autism’s genetic puzzle
An anti-senescence gene may fight spinal disc deterioration
Scientists identify the neuroblastoma cells that signal poor outcomes
Urine test may improve bladder cancer diagnosis and guide treatment decisions
Tracing 700 million years of cell evolution
RNA-Seq reveals a new way the developing heart controls its growth
The Human RNome Project Consortium seeks to publish first-ever complete sequence of the body’s RNA
Unmasking “zombie cells” in aging tissue with an AI-powered barcode
RNA variant imaging for cancer diagnosis
Autism-risk mutations reveal two opposing patterns of brain gene activity
Stay Connected
Submit a Post to the Blog
Recent Posts
Subscribe to the RNA-Seq Blog
RNA-Seq Products & Services